Which form of treatment obtains regression low degree displasia in Barret?

2006, Number 1

Rev Gastroenterol Mex 2006; 71 (1)

Esmer D

Language: Spanish
References: 6
Page: 81
PDF size: 70.72 Kb.

Text Extraction

No abstract

REFERENCES

Jankowski J, Sharma P. Review article: approaches to Barrett’s esophagus treatment –the role of proton pump inhibitors and other interventions. Aliment Pharmacol Ther 2004; 19(Suppl. 1): 54-9.
McCallum R, Polepalle S, Davenport K, et al. Role of anti-reflux surgery against dysplasia in Barrett’s esophagus. Gastroenterology 1991; 100(Suppl.): A121.
Ortiz A, Martínez de Haro LF, Parrilla P, et al. Conservative treatment versus antireflux surgery in Barrett’s oesphagus: long-term results of a prospective study. Br J Surg 1996; 83: 274-8.
Katz D, Rothstein R, Schned A, et al. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett’s esophagus. Am J Gastroenterol 1998; 93: 536-41.
Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease. Follow-up of randomized controlled trial. JAMA 2001; 285: 2331-8.
Parrilla P, Martinez de Haro LF, Ortiz A, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg 2003; 237: 291-8.